Maiwald Magazine

News and Releases

Maiwald Blog

10 Dec 2024 - Maiwald Blog

New referral to the Enlarged Board of Appeal – continuation of the appeal by intervener – T1286/23

In the opposition appeal proceedings “T1286/23”, which we had already reported on “

Continue reading

14 Nov 2024 - Maiwald Blog

Equivalent infringement in different European jurisdictions

As part of our regular internal legal seminars, Dr. Wilhelm Eger held a talk on current developments in infringement under the doctrine of equivalency in various European lega...

Continue reading

11 Nov 2024 - Maiwald Blog

Implementation of the Pharmaceutical Strategy for Europe and the Intellectual Property Action Plan – Part 3

In addition to the pharmaceutical strategy for Europe[1], the European Commission adopted a new action plan for intellectual prop...

Continue reading

All articles

Press Coverage

30 Oct 2024 - Pressebericht

PI decision at UPC local division Munich after withdrawal of the PI request

The article sheds light on preliminary injunction proceedings before the local division of the Unified Patent Court (UPC) in Munich between the applicant Tiroler Rohre (TRM) and the defendants SSAB Swedish Steel GmbH and SSAB Europe Oy concerning pile shoes for anchoring str...

Continue reading

11 Oct 2024 - Pressebericht

Generic drug companies attack Novo Nordisk’s diabetes and weight-loss drug

Generic drug companies have successfully challenged two key Novo Nordisk patents related to the tablet formulation of semaglutide, a blockbuster drug for diabetes (Rybelsus) and weight loss (Wegovy). The European Patent Office’s Boards of Appeal revoked patents EP 2 827 84...

Continue reading

10 Sep 2024 - Pressebericht

Sanofi cabazitaxel patent revoked by Paris court

In the ongoing case between Sanofi and the generic drug manufacturer Accord, the Paris Judicial Court has fully revoked Sanofi’s patent for the chemotherapy drug Jevtana. The patent EP 2 493 466, which protects a new use of cabazitaxel in combination with prednisone or pre...

Continue reading

Maiwald in the press

Staff News

29 Nov 2024 - Personalnachricht

Maiwald congratulates on passing the exam

We would like to congratulate

Continue reading

1 Oct 2024 - Personalnachricht

Dr. Gisela Gerstberger appointed partner at Maiwald

Maiwald, one of Germany's leading intellectual property law firms, has appointed Dr. Gisela Gerstberger as partner with effect from October 1, 2024, thereby expanding its grow...

Continue reading

6 Sep 2024 - Personalnachricht

Maiwald Congratulates on Passing the EQE Examination

We are very pleased to congratulate 

Continue reading

All Staff News

Publications

4 Dec 2024 - Publikation

Proposed regulations for a unitary SPC for medicinal products under the microscope, Managing IP 2024

Dr. Christian Meyer and Dr. Gisela Grabow of Maiwald consider proposals under the European Commission’s Action Plan for Intellectual Property that aim to simplify extended p...

Continue reading

22 Nov 2024 - Publikation

Interview IAM Strategy 300 Global Leaders, 2024

This year, IAM has once again invited leading experts in the field of intellectual property to provide valuable insights, highlight key experiences and share their views on th...

Continue reading

21 Oct 2024 - Publikation

EU pharmaceutical reforms propose changes to regulatory protection periods, Managing IP 2024

Dr. Christian Meyer and Dr. Gisela Grabow discuss potential changes to the EU pharmaceutical regulation and their possible impact on data and market protection timelines for m...

Continue reading

All publications

Awards

25 Nov 2024 - Auszeichnung

Maiwald awarded 1st place by FOCUS as top employer for medium-sized companies in 2025

At Maiwald, we go to great lengths to ensure that all our colleagues feel comfortable and are constantly trying to optimize ourselves in order to achieve and maintain the most...

Continue reading

22 Nov 2024 - Auszeichnung

IAM Strategy 300 Global Leaders 2025

We are delightet that IAM has recognized eight of our partners as Strategy 300 Global Leaders: Dr. Andreas Ledl...

Continue reading

28 Oct 2024 - Auszeichnung

JUVE Patent Rankings Germany 2024

JUVE Patent published the new JUVE Patent Germany ranking 2024 – and our firm is not only recommended in the category “Patent Filing” but also in “

Continue reading

All awards

Events

Mon.

20

20 Jan 2025 |Upcoming|External Events

Pharma & Biotech Patent Litigation Europe Summit 2025 in Amsterdam

We're excited to be a Platinum Partner to the 4th Annual Pharma & Biotech Patent Litigation Europe! Our partner and head of legal Dr. Marco Stief will chair the panel prese...

Continue reading

Thu.

28

28 Nov 2024 |Past Event|LectureVortag Live

PatentFORUM conference 2024

as part of the 44th Patent and Trademark FORUM 2024 The PatentFORUM is your opportunity to exchange ideas with your colleagues at a high level and to keep up to date with the latest developments in patent law.

Continue reading

Wed.

27

27 Nov 2024 |Past Event

Webinar: SPC Manufacturing & Stockpiling Waiver: Legal requirements, opportunities and risks of the SPC Waiver – Regulation (EU) 2019/933

During this webinar, we will discuss key aspects of the SPC Waiver Regulation while referring to recent case law in the Netherlands and Germany: - Scope of Application of the SPC Waiver - Obligations for the Generics and Biosimilar Companies - The Court Decisions in the Hague and Munich. To the webinar recording:...

Continue reading

Wed.

27

27 Nov 2024 |Past Event|Online lecture

Webinar: Protection and funding opportunities for innovations (held in German)

We are pleased to invite you to a joint webinar with Leyton, a leading consultancy in the field of research and development funding. Innovative strength is increasingly becoming a decisive factor for sustainable success - be it through the introduction of new technologies or the improvement of existing p...

Continue reading

All events